Clinical interpretation of PD-L1 status using the 22C3 antibody–based LDT on the BenchMark XT or BenchMark ULTRA platform and PD-L1 IHC 22C3 pharmDx.
收藏数据链接：
官方服务：
资源简介：
Clinical interpretation of PD-L1 status using the 22C3 antibody–based LDT on the BenchMark XT or BenchMark ULTRA platform and PD-L1 IHC 22C3 pharmDx.
创建时间：
2023-06-02
